Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

  • Condition: Relapsed and refractory acute myeloid leukemia
  • Journal: Annals of hematology
  • Treatment Used: Venetoclax
  • Number of Patients: 40
  • Published —
The study researched the outcomes of Venetoclax for patients with relapsed and refractory acute myeloid leukemia.
  • Condition: High-Risk Refractory AML1-ETO Positive Myeloid Leukemia (AML)
  • Journal: Zhongguo shi yan xue ye xue za zhi
  • Treatment Used: Unrelated Umbilical Cord Blood Transplantation (UCBT)
  • Number of Patients: 45
  • Published —
This study analyzed the clinical outcomes of engraftment, graft-versus-host disease (GVHD) and survival in the patients with AML1-ETO positive acute myeloid leukemia (AML) treated with unrelated umbilical cord blood transplantation (UCBT).